{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:39:43Z","timestamp":1771616383817,"version":"3.50.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001463","name":"MINDEF","doi-asserted-by":"publisher","award":["R182-000-210-232"],"award-info":[{"award-number":["R182-000-210-232"]}],"id":[{"id":"10.13039\/501100001463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.antiviral.2016.09.003","type":"journal-article","created":{"date-parts":[[2016,9,12]],"date-time":"2016-09-12T22:47:18Z","timestamp":1473720438000},"page":"207-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Single dose of an adenovirus vectored mouse interferon-\u03b1 protects mice from lethal EV71 challenge"],"prefix":"10.1016","volume":"134","author":[{"given":"Jialei","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Ennis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin Jang Hann","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.09.003_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1128\/JVI.74.3.1513-1523.2000","article-title":"Alpha\/beta interferons potentiate virus-induced apoptosis through activation of the FADD\/Caspase-8 death signaling pathway","volume":"74","author":"Balachandran","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.09.003_bib2","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1128\/AAC.00397-10","article-title":"Inhibition of dengue virus by an ester prodrug of an adenosine analog","volume":"54","author":"Chen","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.003_bib3","doi-asserted-by":"crossref","first-page":"e79783","DOI":"10.1371\/journal.pone.0079783","article-title":"Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers","volume":"8","author":"Chou","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.09.003_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.05.004","article-title":"Protection against Chikungunya virus induced arthralgia following prophylactic treatment with adenovirus vectored interferon (mDEF201)","volume":"108","author":"Dagley","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.003_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.5","article-title":"Type 1 interferon gene transfer enhances host defense against pulmonary Streptococcus pneumoniae infection via activating innate leukocytes","volume":"1","author":"Damjanovic","year":"2014","journal-title":"Mol. Ther. \u2014 Methods & Clin. Dev."},{"key":"10.1016\/j.antiviral.2016.09.003_bib6","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.174.5.1179","article-title":"Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice","volume":"174","author":"Finkelman","year":"1991","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.antiviral.2016.09.003_bib7","doi-asserted-by":"crossref","first-page":"e26072","DOI":"10.1371\/journal.pone.0026072","article-title":"Use of recombinant adenovirus vectored consensus IFN-a to avert severe arenavirus infection","volume":"6","author":"Gowen","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.09.003_bib8","first-page":"109","article-title":"Manipulation of adenovirus vectors","volume":"vol. 7","author":"Graham","year":"1991"},{"key":"10.1016\/j.antiviral.2016.09.003_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S1074-7613(03)00208-5","article-title":"Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6","volume":"19","author":"Jego","year":"2003","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2016.09.003_bib10","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1128\/AAC.01635-10","article-title":"Treatment of yellow fever virus with an adenovirus-vectored interferon, DEF201, in a hamster model","volume":"55","author":"Julander","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.09.003_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2010.11.007","article-title":"Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB\/c mouse mode","volume":"89","author":"Kumaki","year":"2011","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.09.003_bib12","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1074-7613(01)00126-1","article-title":"Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in\u00a0vivo","volume":"14","author":"Le","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2016.09.003_bib13","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.vaccine.2014.10.081","article-title":"Considerations for developing an immunization strategy with enterovirus 71 vaccine","volume":"33","author":"Li","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.antiviral.2016.09.003_bib14","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1099\/vir.0.81195-0","article-title":"Type I interferons protect mice against enterovirus71 infection","volume":"86","author":"Liu","year":"2005","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.09.003_bib15","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4049\/jimmunol.134.1.299","article-title":"Stimulation of in\u00a0vitro immunoglobulin production by interferon-alpha","volume":"134","author":"Neubauer","year":"1985","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.antiviral.2016.09.003_bib16","doi-asserted-by":"crossref","first-page":"e0116722","DOI":"10.1371\/journal.pone.0116722","article-title":"Rift valley fever virus infection in golden syrian hamsters","volume":"10","author":"Scharton","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.09.003_bib17","series-title":"Sinovac Obtains New Drug Certificate and Production License for EV71 Vaccine","year":"2016"},{"key":"10.1016\/j.antiviral.2016.09.003_bib18","doi-asserted-by":"crossref","first-page":"e26330","DOI":"10.1371\/journal.pone.0026330","article-title":"Therapy and long-term prophylaxis of vaccinia virus respiratory infections in mice with an adenovirus-vectored interferon alpha (mDEF201)","volume":"6","author":"Smee","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.antiviral.2016.09.003_bib19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.biochem.67.1.227","article-title":"How cells respond to interferons","volume":"67","author":"Stark","year":"1998","journal-title":"Ann. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2016.09.003_bib20","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature01850","article-title":"Integration of interferon-alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence","volume":"424","author":"Takaoka","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2016.09.003_bib21","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.immuni.2006.08.014","article-title":"Complex modulation of cell type-specific signaling in response to type I interferons","volume":"25","author":"van Boxel-Dezaire","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.antiviral.2016.09.003_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/376998","article-title":"Pathogenesis of enterovirus 71 brainstem encephalitis in pediatric patients: roles of cytokines and cellular immune activation in patients with pulmonary edema","volume":"188","author":"Wang","year":"2003","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.09.003_bib23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2007.07.024","article-title":"Pre- and post-exposure protection against Western equine encephalitis virus after single inoculation with adenovirus vector expressing interferon alpha","volume":"369","author":"Wu","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2016.09.003_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3851\/IMP1720","article-title":"Potent inhibition of human enterovirus 71 replication by type I interferon subtypes","volume":"16","author":"Yi","year":"2011","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2016.09.003_bib25","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(12)61764-4","article-title":"Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216303643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:18:44Z","timestamp":1749579524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216303643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":25,"alternative-id":["S0166354216303643"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.003","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single dose of an adenovirus vectored mouse interferon-\u03b1 protects mice from lethal EV71 challenge","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}